These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 6596301)
1. The pharmacokinetics and tissue penetration of ofloxacin. Lockley MR; Wise R; Dent J J Antimicrob Chemother; 1984 Dec; 14(6):647-52. PubMed ID: 6596301 [TBL] [Abstract][Full Text] [Related]
2. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin. Wise R; Lister D; McNulty CA; Griggs D; Andrews JM Infection; 1986; 14 Suppl 3():S196-202. PubMed ID: 3463542 [TBL] [Abstract][Full Text] [Related]
3. Ofloxacin: serum and skin blister fluid pharmacokinetics in the fasting and non-fasting state. Kalager T; Digranes A; Bergan T; Rolstad T J Antimicrob Chemother; 1986 Jun; 17(6):795-800. PubMed ID: 3460984 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tissue penetration of enoxacin. Wise R; Lockley R; Dent J; Webberly M Antimicrob Agents Chemother; 1984 Jul; 26(1):17-9. PubMed ID: 6591851 [TBL] [Abstract][Full Text] [Related]
5. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent. Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701 [TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics and tissue penetration of norfloxacin. Adhami ZN; Wise R; Weston D; Crump B J Antimicrob Chemother; 1984 Jan; 13(1):87-92. PubMed ID: 6230344 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure. Nawishy S; Moukhtar I; Sabbour M Chemioterapia; 1986 Dec; 5(6):391-3. PubMed ID: 3467875 [TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of ofloxacin and a review of its tissue penetration. Wise R; Lockley MR J Antimicrob Chemother; 1988 Sep; 22 Suppl C():59-64. PubMed ID: 3182463 [TBL] [Abstract][Full Text] [Related]
9. The comparative pharmacokinetics of five quinolones. Wise R; Lister D; McNulty CA; Griggs D; Andrews JM J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule. Wise R; Griggs D; Andrews JM Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327 [TBL] [Abstract][Full Text] [Related]
12. The effect of food on the pharmacokinetics of ofloxacin. Verho M; Malerczyk V; Dagrosa E; Korn A Curr Med Res Opin; 1986; 10(3):166-71. PubMed ID: 3460737 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219). Wise R; Mortiboy D; Child J; Andrews JM Antimicrob Agents Chemother; 1996 Jan; 40(1):47-9. PubMed ID: 8787877 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone. Wise R; Kirkpatrick B; Ashby J; Griggs DJ Antimicrob Agents Chemother; 1987 Feb; 31(2):161-3. PubMed ID: 3105446 [TBL] [Abstract][Full Text] [Related]
15. Dose linearity and other pharmacokinetics of ofloxacin: a new, broad-spectrum antimicrobial agent. Verho M; Malerczyk V; Dagrosa E; Korn A Pharmatherapeutica; 1985; 4(6):376-82. PubMed ID: 3866256 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose. Gee T; Andrews JM; Ashby JP; Marshall G; Wise R J Antimicrob Chemother; 2001 Apr; 47(4):431-4. PubMed ID: 11266415 [TBL] [Abstract][Full Text] [Related]